About Us

TGR BioSciences Pty Ltd (TGR) is located in Adelaide, South Australia. Established in 2001, TGR is committed to providing innovative solutions for cell-based research applications. TGR has R&D, Manufacturing, Quality and Logistics functions and active in the Life Science, Pharmaceutical and Diagnostics markets.  In January 2020, TGR was acquired by Abcam whose headquarters are in Cambridge, UK.  ​​Abcam develops and produces high-quality biological reagents – primarily RabMabs – which are essential in a wide range of fields and applications including drug discovery, diagnostics and basic research.

TGR’s core products are underpinned by its patented CaptSure™ technology which is characterized by its innovative peptide-antibody immobilization system.  The key attributes of TGR’s CaptSure™ technology are simplicity, speed and efficiency and it is these 3 attributes that make CaptSure™ s the ‘go-to’ platform for the development and manufacture of high-quality immunoassays. TGR’s flagship immunoassay range, SureFire® Ultra, underpins a range of assay kits for analysis of cellular phosphoproteins and are manufactured at its facility in Adelaide. SureFire® Ultra kits are distributed exclusively through Revvity, Inc. (USA), a global market leader in laboratory reagents. With over 300 assays on the market TGR’s SureFire® Ultra and SureFire® Multiplex assays provide an unparalleled toolbox for measuring endogenous signaling proteins in a homogeneous format.

All TGR SureFire® Ultra related products are available globally through our exclusive distributor Revvity, visit www.revvity.com. The CaptSure™ SimpleStep ELISA technology is available globally through our parent company, Abcam plc, visit www.abcam.com.